New medicine for moderate-to-severe plaque psoriasis
Part of Immune system & allergy, Skin clinical trials.
This study tests a new medicine (HS-20137) for moderate-to-severe plaque psoriasis, a condition causing thick, scaly patches on the skin. It aims to see if this medicine can safely reduce the severity of psoriasis and improve quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You must have had plaque psoriasis for at least 6 months.
- Your psoriasis must be moderate to severe – covering at least 10% of your body surface (that's about 10 palms of your hand) and with a doctor's assessment of severity.
- You should be someone who can take systemic treatments (pills or injections) or light therapy.
- You must not have used certain psoriasis treatments before the study, or you must have stopped them in time (like biologics within months, or other treatments within weeks).
- You should not have other skin conditions or autoimmune diseases that could interfere, or a history of serious or repeated infections.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational medicine (HS-20118) for people with moderate-to-severe plaque psoriasis. The goal is to see if the drug can safely and effectively reduce psoriasis symptoms and improve quality of life.
This study tests an experimental oral tablet (CMS-D001) to see if it can safely and effectively reduce the severity of moderate to severe plaque psoriasis. It may be an easier treatment option compared to injections or light therapy.
This study tests an experimental once-daily tablet for adults with moderate-to-severe plaque psoriasis who haven't had enough relief from standard creams or light therapy. The goal is to see if it can clear skin more effectively than placebo.
This trial tests a new medication (HS-10374) taken by mouth to see if it is safe and effective for people with moderate to severe plaque psoriasis. It might help reduce the redness, scaling, and thickness of psoriasis plaques.
This trial tests an experimental pill that may help clear psoriasis plaques. It is for people whose current topical treatments (creams or ointments) are not working well enough or cause side effects.
This study tests an oral medication (HSK47388) as a treatment for moderate-to-severe plaque psoriasis, the most common type. It may help reduce symptoms like red, scaly patches and improve quality of life.
Hear when a new Moderate to Severe Plaque Psoriasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.